Combination of antiangiogenic molecules with chemotherapeutics is considered a valuable strategy to increase cancer cell killing through decreased blood supply to the tumor. Our final aim is to develop biodegradable nanoparticles (NPs) which accumulate in cancer cells through folate receptor (FR) and bearing an antiangiogenic anti-FLT1 hexapeptide, which inhibits VEGF-induced endothelial cell migration and angiogenesis. Docetaxel (DTX) was selected as model of poorly water-soluble chemotherapeutics.
Antiangiogenic biodegradable nanoparticles as an advanced approach to enhance antitumor effects
Giovanni dal Poggetto;Paola Laurienzo;
2017
Abstract
Combination of antiangiogenic molecules with chemotherapeutics is considered a valuable strategy to increase cancer cell killing through decreased blood supply to the tumor. Our final aim is to develop biodegradable nanoparticles (NPs) which accumulate in cancer cells through folate receptor (FR) and bearing an antiangiogenic anti-FLT1 hexapeptide, which inhibits VEGF-induced endothelial cell migration and angiogenesis. Docetaxel (DTX) was selected as model of poorly water-soluble chemotherapeutics.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
